Literature DB >> 21355790

Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment.

Anna Alisi1, Stefano Cianfarani, Melania Manco, Carlo Agostoni, Valerio Nobili.   

Abstract

In the last three decades the incidence of metabolic syndrome (MetS) has been growing worldwide along with an increase of obesity, type 2 diabetes mellitus, and non-alcoholic fatty liver disease (NAFLD). In children and adolescents such epidemics are particularly worrisome, since the metabolic consequences in adulthood will significantly burden the health care system. Although the definition of MetS in childhood is still controversial, there is agreement with respect to NAFLD being the hepatic manifestation of MetS. However, the molecular pathogenesis of MetS and its contribution to NAFLD is complex and closely related to the pre- and postnatal environment as well as to genetic predisposing factors. The analysis of the possible relationships between NAFLD and MetS is particularly interesting, not only from an epidemiological point of view, but also to better understand the genetic and environmental factors contributing to the development of both diseases. We here summarize the most recent epidemiological data on the incidence of both diseases in adolescents, and several aspects linking MetS with NAFLD, discussing the possible role played by genetics and intrauterine environment.

Entities:  

Mesh:

Year:  2011        PMID: 21355790     DOI: 10.3109/07853890.2010.547869

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  25 in total

1.  Schisandra chinensis Baill, a Chinese medicinal herb, alleviates high-fat-diet-inducing non-alcoholic steatohepatitis in rats.

Authors:  Zheng Yao; Xiao-Chen Liu; Ying-Er Gu
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

2.  Nonalcoholic fatty liver disease: Targeted therapy in children--what is the right way?

Authors:  Anna Alisi; Valerio Nobili
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-12       Impact factor: 46.802

Review 3.  Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

Authors:  Anna Alisi; Ariel E Feldstein; Alberto Villani; Massimiliano Raponi; Valerio Nobili
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-17       Impact factor: 46.802

4.  Liver volume and hepatic adiposity in childhood: relations to body growth and visceral fat.

Authors:  R Malpique; J Bassols; A López-Bermejo; M Diaz; F Villarroya; J Pavia; A Congo; F de Zegher; L Ibáñez
Journal:  Int J Obes (Lond)       Date:  2017-08-14       Impact factor: 5.095

5.  Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.

Authors:  Elisabetta Bugianesi; Carla Bizzarri; Chiara Rosso; Antonella Mosca; Nadia Panera; Silvio Veraldi; Andrea Dotta; Germana Giannone; Massimiliano Raponi; Marco Cappa; Anna Alisi; Valerio Nobili
Journal:  Am J Gastroenterol       Date:  2017-05-30       Impact factor: 10.864

6.  Selection of reference genes for expression analyses in liver of rats with impaired glucose metabolism.

Authors:  Alfonso H Hernández; Rui Curi; Luis A Salazar
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

7.  Pulmonary function test abnormalities in children and adolescents with non-alcoholic fatty liver disease.

Authors:  Doaa El Amrousy; Heba El Ashry; Sara Maher; Salwa Ganna; Samir Hasan
Journal:  Eur J Pediatr       Date:  2021-01-21       Impact factor: 3.183

8.  The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD).

Authors:  D Liccardo; A Mosca; S Petroni; P Valente; U Giordano; A G A Mico'; S Pescosolido; L Buzzonetti; Valerio Nobili
Journal:  J Gastroenterol       Date:  2014-12-17       Impact factor: 7.527

9.  Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.

Authors:  A Alisi; G Bedogni; G Baviera; V Giorgio; E Porro; C Paris; P Giammaria; L Reali; F Anania; V Nobili
Journal:  Aliment Pharmacol Ther       Date:  2014-04-16       Impact factor: 8.171

10.  PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations.

Authors:  Elena Larrieta-Carrasco; Victor Acuña-Alonzo; Rafael Velázquez-Cruz; Rodrigo Barquera-Lozano; Paola León-Mimila; Hugo Villamil-Ramírez; Marta Menjivar; Sandra Romero-Hidalgo; Nahúm Méndez-Sánchez; Vanessa Cárdenas; Manuel Bañuelos-Moreno; Yvonne N Flores; Manuel Quiterio; Jorge Salmerón; Fausto Sánchez-Muñoz; Teresa Villarreal-Molina; Carlos A Aguilar-Salinas; Samuel Canizales-Quinteros
Journal:  Mol Biol Rep       Date:  2014-04-02       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.